Metabolic syndrome tertiary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Metabolic syndrome}} | {{Metabolic syndrome}} | ||
{{CMG}} | |||
==Overview== | |||
==Tertiary Prevention== | |||
==References== | ==References== | ||
Line 11: | Line 14: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Needs overview]] |
Latest revision as of 20:06, 12 July 2016
Metabolic syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Metabolic syndrome tertiary prevention On the Web |
American Roentgen Ray Society Images of Metabolic syndrome tertiary prevention |
Risk calculators and risk factors for Metabolic syndrome tertiary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]